Skip to main content

Advertisement

SpringerLink
Log in

Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: Do they exist?

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Hormone replacement therapy (HRT) prevents postmenopausal bone loss, but the prevalence of non-responders in healthy early postmenopausal women is not known. In order to study this, we reviewed data from three published studies, each carried out in a randomized, placebo-controlled, longitudinal design over 2 year, that used seven hormone replacement therapies. Bone mineral content (BMC) was measured in the distal forearm by single photon absorptiometry. A mathematical model for elimination of measurement errors was applied to published BMC data. After this correction, we found that only 1.2% of early healthy postmenopausal women who are receiving HRT in conventional doses will lose more than 1% of forearm BMC per year. In conclusion, most, if not all, healthy early postmenopausal women who might need HRT against loss of bone will respond positively in forearm BMC to such therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Conference Report. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1991;90: 107–10

    Google Scholar 

  2. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980;10:273–9.

    CAS  PubMed  Google Scholar 

  3. Riis BJ, Jensen J, Christiansen C. Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy. Clin Endocrinol 1987;26:327–34.

    CAS  Google Scholar 

  4. Riis BJ, Thomsen K, Strøm V, Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol 1987;156:61–5.

    CAS  PubMed  Google Scholar 

  5. Marslew U, Overgaard K, Riis BJ, Christiansen C. Two new combinations of estrogen and progestogens for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol 1992;79:202–10

    CAS  PubMed  Google Scholar 

  6. Marslew U, Riis BJ, Christiansen C. Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Eur J Clin Invest 1991;21:601–7.

    CAS  PubMed  Google Scholar 

  7. Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Am J Med 1991;90:584–9.

    CAS  PubMed  Google Scholar 

  8. Nilas L, Christiansen C. Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 1988;18:529–34.

    CAS  PubMed  Google Scholar 

  9. Nilas L, Borg J, Gotfredsen A, Christiansen C. Comparison of single and dual photon absorptiometry in postmenopausal bone mineral loss. J Nucl Med 1985;26:1257–62.

    CAS  PubMed  Google Scholar 

  10. Schlesselman JJ. Planning a longitudinal study. II. Frequency of measurements and study duration. J Chronic Dis 1973;26:561–570.

    CAS  PubMed  Google Scholar 

  11. Civitelli R, Gonnelli S, Zacchei F, et al. Bone turnover in postmenopausal osteoporosis: effect on calcitonin treatment. J Clin Invest 1988;82:1268–74.

    CAS  PubMed  Google Scholar 

  12. Lindsay R, Aitken JM, And erson JB, Hart DM, MacDonald EB, Clarke AC. Long-term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976;1:1038–41.

    CAS  PubMed  Google Scholar 

  13. Lindsay R, Hart DM, Forrest C, Baird C. Prevention of spinal osteoporosis in oophorectomized women. Lancet 1980;2:1151–4.

    CAS  PubMed  Google Scholar 

  14. Nachtigall LE, Nachtigall RH, Nachtigall RD, Bechman EM. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979;53:277–81.

    CAS  PubMed  Google Scholar 

  15. Christiansen C, Riis BJ. Five years with continuous combined oestrogen/progestogen therapy: effects on calcium metabolism, lipoproteins, and bleeding pattern. Br J Obstet Gynecol 1990;97:1087–92.

    CAS  Google Scholar 

  16. Gotfredsen A, Nilas L, Riis BJ, Thomsen K, Christiansen C. Bone changes occurring spontaneously and caused by oestrogen in early postmenopausal women: a local or generalized phenomenon? BMJ 1986;292:1098–100.

    CAS  PubMed  Google Scholar 

  17. Gotfredsen A, Riis BJ, Christiansen C. Total and local bone mineral during estrogen treatment: a placebo controlled trial. Bone Miner 1986;1:167–73.

    CAS  PubMed  Google Scholar 

  18. Riis BJ, Christiansen C. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988;84:646–53.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Clinical and Basic Research, Ballerup Byvej 222, 2750, Ballerup, Denmark

    C. Hassager, S. B. Jensen & C. Christiansen

Authors
  1. C. Hassager
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. B. Jensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Christiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassager, C., Jensen, S.B. & Christiansen, C. Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: Do they exist?. Osteoporosis Int 4, 36–41 (1994). https://doi.org/10.1007/BF02352259

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02352259

Keywords

Search

Navigation